GoalVest Advisory »

Viking Therapeutics shares owned by GoalVest Advisory

Quarter-by-quarter ownership of Viking Therapeutics (VKTX) shares owned by GoalVest Advisory from 13F filings

Historical chart of GoalVest Advisory investment in Viking Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Viking Therapeutics held by GoalVest Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Viking Therapeutics by GoalVest Advisory

Quarter filed Position value Share count Share price at filing
2026-03-31 $4.9k 150 32.54
2025-12-31 $5.3k 150 35.18

More positions owned by GoalVest Advisory

Vanguard S&p 500 Etf Etf (VOO)
Vanguard Growth Etf Etf (VUG)
State Street Spdr Portfolio Intermediate Term Corporate Bond Etf Etf (SPIB)
Goldman Sachs Municipal Income Etf Etf (GMUB)
State Street Spdr Nyse Technology Etf Etf (XNTK)
Ishares Core Msci Eafe Etf Etf (IEFA)
Vanguard Total Stock Market Etf Etf (VTI)
Vanguard Ftse Europe Etf Etf (VGK)
Goldman Sachs Physical Gold Etf Etf (AAAU)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Nvidia Corporation Stock (NVDA)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Microsoft Corp Stock (MSFT)
Spear Alpha Etf Etf (SPRX)
Palantir Technologies Inc Cl A Stock (PLTR)

View all positions for GoalVest Advisory

Top funds holding Viking Therapeutics

Vanguard Group
BlackRock
FMR
Susquehanna International
Vanguard Capital Management
Vanguard Portfolio Management
State Street Corporation
Two Sigma Investments
Morgan Stanley
Citadel Advisors
Geode Capital Management
Ameriprise Financial
D. E. Shaw & Co
UBS Group
Diadema Partners

View all funds holding Viking Therapeutics